Sharlene Gill

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Sharlene Gill, Charles L. Loprinzi, Daniel J. Sargent et al. · Journal of Clinical Oncology · 2004 · 1K citations

Medicine, Oncology, Chemotherapy +16

Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna et al. · Journal of Clinical Oncology · 2009 · 643 citations · Full text

Medicine, Oncology, Pharmacology +12

PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy

Sharlene Gill, Yoo‐Joung Ko, C. Cripps et al. · Journal of Clinical Oncology · 2016 · 291 citations

Medicine, Oncology, Pharmacotherapy +13

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Kerry S. Courneya, Janette L. Vardy, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2025 · 256 citations

Medicine, Health Education, Oncology +17

The Colon Health and Life-Long Exercise Change Trial: A Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group

Kerry S. Courneya, Christopher M. Booth, Sharlene Gill et al. · Current Oncology · 2008 · 176 citations · Full text

Medicine, Health Behavior, Oncology +17